IPO Boutique

Genprex, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Genprex, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Genprex, Inc.GNPX -
NASDAQ
$5.00-$5.00 $5.00 $4.691.3 million3/29/2018
Network 1 Financial
Co-Manager(s):
Health Care
Filing(s):

Filed 2017-07-21
Terms Added 2017-09-08
Terms Changed 2017-10-10
Updated Prospectus 2018-01-22



Genprex, Inc. Quote & Chart - Click for current quote - GNPX

About Genprex, Inc. (adapted from Genprex, Inc. prospectus):
Genprex is a clinical stage gene therapy company developing a new approach to treating cancer, based upon their novel proprietary technology platform, including their initial product candidate, Oncoprex immunogene therapy, or Oncoprex.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "GNPX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved